DOI：10.12201/bmr.202004.00024

Carrimycin alleviates fibrogenesis in Bile Duct Ligated rats and human fibroblasts by suppressing inflammation

•  

  Abstract: Aims: Fibrosis is a tissue repair compensatory response that is majorly characterized by excess accumulation of fibrous connective tissue resulting in progressive architectural remodeling in nearly all tissues and organs, such as liver, kidney, lung, heart and skin. Liver fibrosis is a vital cause of morbidity of patients with liver diseases, ultimately leading to liver cirrhosis, liver failure and even hepatocellular carcinoma, it is imperative to develop novel antifibrotic drugs for prevention or reversal of liver fibrosis. Carrimycin (CAM), a new genetic engineering 16-membered macrolide antibiotic, has been applied to upper respiratory infections, little is known about its ability to prevent hepatic injury and fibrosis. The aim of the present study is to evaluate the functional roles and mechanism of CAM in protecting against liver injury and fibrosis in bile duct ligated (BDL) rats and human fibroblasts. Result: CAM reduced the mRNA and protein levels of TGFβ1, COL1A1 and α-SMA induced by TGFβ1 in human hepatic stellate cells LX-2, human lung fibroblasts MRC5 and human skin fibroblasts CCC-ESF-1. In BDL rats, biochemical result showed that CAM treatment reduced indicators levels of γ-GT, HDL in the serum and TBA, TBiL in urine. The pathological H&E stained sections showed that CAM significantly reduced the bile duct proliferation and inflammation infiltration induced by BDL, area and density of collagen fibers in Sirius red stained sections decreased markedly as well. Furthermore, CAM also inhibited the mRNA expression of Col1a1, Acta2, Tgfb1, Mmp2 and Mmp9 in rat liver tissue. The mRNA expression of Tnfα and Il-1b, and protein levels of IL-1β and NF-κB in the inflammatory pathway were significantly suppressed by CAM treatment, and immunohistochemistry of liver tissue showed a significant decrease in the levels of NF-κB and F4/80. Conclusion: These results demonstrate that CAM ameliorates BDL-induced liver damage and fibrosis in rats by suppressing inflammation, and reduces fibrogenesis induced by TGFβ1 in human fibroblast cells LX-2, MRC5 and CCC-ESF-1, which suggests that CAM might be a novel antifibrotic candidate that protect against fibrosis in liver and in other tissue.

  Key words: liver fibrosis; Carrimycin (CAM); BDL; NF-κB

  提交时间：2020-04-20

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 赫曼, 杜杰, 杨磊, 李斌, 杨毅, 徐时, 柴琛. 鸢尾素在脓毒症大鼠头端延髓腹外侧区的心血管效应. 2020. doi: 10.12201/bmr.202011.00002

  王昕. 杨志宏治疗肝阳上亢型高血压性眩晕的临床经验. 2020. doi: 10.12201/bmr.202004.00008

  加焱冰, 石振宇, 何平, 孟庆跃. 我国卫生政策与体系研究人力资源现状分析. 2020. doi: 10.12201/bmr.202006.00008

  翟运开, 张然, 路薇, 赵杰. 互动感知对邀请方医生持续参与远程医疗意愿影响研究. 2020. doi: 10.12201/bmr.202007.00022

  朱彦, ZHENG Jie, 李晓瑛, 杨啸林, HE Yongqun. 基本形式化本体BFO及中文版介绍. 2020. doi: 10.12201/bmr.202007.00009

  郭强, 凌鸿, 杨军, 林伟龙, 武志慧, 闵浩巍, 史文钊, 时黎明, 马建辉. 多中心生物样本资源共享与应用平台建设探索. 2020. doi: 10.12201/bmr.202007.00018

  桑宇慧, 肖勇, 沈绍武, 田双桂. 我国三级中医医院信息化人才队伍现状分析与思考. 2020. doi: 10.12201/bmr.202008.00012

  王玲, 易钢. 基于物联网技术的运动监测评价系统的研究与分析. 2020. doi: 10.12201/bmr.202003.00072

  闫慈, 王鹏, 杨越, 任劲, 吴睿豪, 管音, 张茜. 省级肿瘤大数据中心的规划与建设. 2020. doi: 10.12201/bmr.202009.00002

  许佳, 罗凯, 杨毅, 张梦娇, 张艺鹏, 白丁. 基于医疗信息化人才现状和需求的人才培养方案探析. 2020. doi: 10.12201/bmr.202009.00012

• 序号	提交日期	编号	操作
  1	2020-04-20	bmr.202004.00024V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论